Seth Loring Harrison Insider Trading $AKRO Akero Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Seth Loring Harrison.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Seth Loring Harrison. Seth Loring Harrison is Director in HeartWare International, Inc. ($HTWR) and in Tokai Pharmaceuticals Inc ($TKAI) and Director in Stoke Therapeutics, Inc. ($STOK) and Director in Akero Therapeutics, Inc. ($AKRO).
Seth Loring Harrison in Akero Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Seth Loring Harrison: Director
Holdings: 5,830,203 shares
Latest Transaction: Jul 14 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Seth Loring Harrison in Akero Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKRO, ELDN, HTWR, STOK
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 14 2020 | AKRO | Akero Therapeutics ... | Harrison Seth Loring | Director | Buy | P | 36.00 | 415,000 | 14,940,000 | 5,830,203 | 5.4 M to 5.8 M (+7.66 %) |
| Jul 14 2020 | AKRO | Akero Therapeutics ... | Harrison Seth Loring | Director | Buy | P | 36.00 | 415,000 | 14,940,000 | 5,830,203 | 5.4 M to 5.8 M (+7.66 %) |
| Jun 02 2020 | AKRO | Akero Therapeutics ... | Harrison Seth Loring | Director | Option Exercise | A | 25.20 | 13,000 | 327,600 | 13,000 | |
| Nov 12 2019 | AKRO | Akero Therapeutics ... | Harrison Seth Loring | Director | Option Exercise | A | 19.97 | 26,000 | 519,220 | 26,000 | |
| Jun 25 2019 | AKRO | Akero Therapeutics ... | Harrison Seth Loring | Director | Option Exercise | C | 0.00 | 880,568 | 0 | 0 | |
| Jun 25 2019 | AKRO | Akero Therapeutics ... | Harrison Seth Loring | Director | Option Exercise | C | 0.00 | 13,000,000 | 0 | 0 | |
| Jun 25 2019 | AKRO | Akero Therapeutics ... | Harrison Seth Loring | Director | Buy | P | 16.00 | 900,000 | 14,400,000 | 5,415,203 | 4.5 M to 5.4 M (+19.93 %) |
| Jun 25 2019 | AKRO | Akero Therapeutics ... | Harrison Seth Loring | Director | Buy | C | 0.00 | 286,439 | 0 | 4,515,203 | 4.2 M to 4.5 M (+6.77 %) |
| Jun 25 2019 | AKRO | Akero Therapeutics ... | Harrison Seth Loring | Director | Buy | C | 0.00 | 4,228,764 | 0 | 4,228,764 | 0 to 4.2 M |
Page: 1